Table 1.
Summary statistics of studies assessing clinical decision support for oncology clinical care.
Characteristic | N | % |
---|---|---|
Full text articles included in analysis | 24 | 100 |
Study population | ||
Adult | 23 | 96 |
Pediatric | 1 | 4 |
Cancer Diagnosis | ||
Any cancer diagnosis | 17 | 71 |
Multiple cancer diagnoses included | 1 | 4 |
Breast | 4 | 17 |
Prostate | 1 | 4 |
Renal Cell | 1 | 4 |
Outcome Samples Studied | ||
Patients | 5730 | - |
Clinicians | 276 | - |
Clinician Hours | 228 | - |
Decisions | 521 | - |
Chemotherapy Orders | 76619 | - |
Chemotherapy Order Sets | 9838 | - |
Medication related events | 212 | - |
Radiation Therapy Courses | 7904 | - |
Study Design | ||
Randomized Controlled Trial | 3 | 13 |
Non-randomized | 21 | 87 |
Pre-post | 10 | 48 |
Cross-sectional | 7 | 33 |
Other | 4 | 19 |
Site Number | ||
Single | 19 | 79 |
Multi-site | 5 | 21 |
Site Type | ||
Inpatient | 7 | 29 |
Outpatient | 5 | 21 |
Not Specified | 12 | 50 |
CDS System Type | ||
CPOE | 12 | 50 |
Clinical Pathway | 6 | 25 |
CPG | 2 | 8 |
PRO | 3 | 13 |
Prescriber Alert | 1 | 4 |
CDS Tool Type | ||
Integrated into EHR | 13 | 54 |
Integrated into Other System | 1 | 4 |
Internet-based | 2 | 8 |
Standalone | 8 | 33 |
Country | ||
United States | 9 | 38 |
Europe | 9 | 38 |
Canada | 1 | 4 |
Korea | 1 | 4 |
Pakistan | 1 | 4 |
Study Funding Source | ||
Not specified | 12 | 50 |
NIH | 2 | 8 |
Other National Program | 4 | 16 |
Foundation | 2 | 8 |
Industry | 1 | 4 |
Local/Site | 3 | 13 |
Taiwan | 3 | 13 |
Conflict of Interest Disclosure | ||
Not Reported | 10 | 42 |
None | 11 | 46 |
Affiliated with For-profit Entity | 3 | 13 |